| Package | dk.kip.rkkp.fhir.ig.core |
| Resource Type | ValueSet |
| Id | ATCDMPN |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-ATCDMPN.html |
| URL | https://kip.rkkp.dk/fhir/ValueSet/ATCDMPN |
| Version | 2.12.0 |
| Status | active |
| Date | 2022-07-14T00:00:00+02:00 |
| Name | ATCDMPN |
| Title | ATC DMPN |
| Description | ATC koder DMPN behandling. Erstattet af nyt VS fra okt. 2024 |
No resources found
| CodeSystem | |
| ATC | WHO ATC |
| GenericValues | Generic values |
| TreatmentUnspecified | Treatment unspecified |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet ATCDMPN
This value set includes codes based on the following rules:
FHIRhttps://kip.rkkp.dk/fhir/CodeSystem/ATC| Code | Display | Definition |
| B01AC06 | Acetylsalicylsyre (ASA) | B01AC06 - acetylsalicylic acid |
| L01XX35 | Anagrelide | L01XX35 - anagrelide |
| L01AB01 | Busulfan (Myleran) | L01AB01 - busulfan |
| L01XX05 | Hydroxcarbamid | L01XX05 - hydroxycarbamide |
| C10AA | Statiner | C10AA - HMG CoA reductase inhibitors |
| L01XH | HDAC hæmmer | L01XH - Histone deacetylase (HDAC) inhibitors |
| L03AB | Interferon | L03AB - Interferons |
| L01EJ01 | Ruxolitinib | L01EJ01 - ruxolitinib |
| L04AA | JAK-2 inhibitorer | L04AA - Selective immunosuppressants |
| B01A | Anden blodfortyndende behandling | B01A - ANTITHROMBOTIC AGENTS |
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified| Code | Display | Definition |
| incision_vein | Venesection | Incision of Vein / Venesektion |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues| Code | Display | Definition |
| other | Anden behandling | Other - used to choose unspecific value not in a valueset |
{
"resourceType": "ValueSet",
"id": "ATCDMPN",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "https://kip.rkkp.dk/fhir/ValueSet/ATCDMPN",
"version": "2.12.0",
"name": "ATCDMPN",
"title": "ATC DMPN",
"status": "active",
"experimental": true,
"date": "2022-07-14T00:00:00+02:00",
"publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact": [
{
"name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom": [
{
"system": "url",
"value": "https://trifork.com"
},
{
"system": "email",
"value": "rbk@trifork.com"
}
]
}
],
"description": "ATC koder DMPN behandling. Erstattet af nyt VS fra okt. 2024",
"compose": {
"include": [
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"concept": [
{
"code": "B01AC06",
"display": "Acetylsalicylsyre (ASA)"
},
{
"code": "L01XX35",
"display": "Anagrelide"
},
{
"code": "L01AB01",
"display": "Busulfan (Myleran)"
},
{
"code": "L01XX05",
"display": "Hydroxcarbamid"
},
{
"code": "C10AA",
"display": "Statiner"
},
{
"code": "L01XH",
"display": "HDAC hæmmer"
},
{
"code": "L03AB",
"display": "Interferon"
},
{
"code": "L01EJ01",
"display": "Ruxolitinib"
},
{
"code": "L04AA",
"display": "JAK-2 inhibitorer"
},
{
"code": "B01A",
"display": "Anden blodfortyndende behandling"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified",
"concept": [
{
"code": "incision_vein",
"display": "Venesection"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
"concept": [
{
"code": "other",
"display": "Anden behandling"
}
]
}
]
}
}